Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.40 +0.41 (+2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Interest & Investment Income (2021 - 2026)

Updated

Viridian Therapeutics, Inc.\DE's Interest & Investment Income came in at $8.49 million for Q2 2026, up 29.7% from $6.55 million a year earlier and up 7.9% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Interest & Investment Income (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Viridian Therapeutics, Inc.\DE reported Interest & Investment Income of $29.68 million, down 1.5% year-over-year; for FY2025, it was $27.4 million, down 13.3% from FY2024.

  • Interest & Investment Income carries a four-year compound annual growth rate of 204.7% (FY2021 to FY2025).
  • Going back by year, Interest & Investment Income was $31.6 million in FY2024 (+73.2%), $18.24 million in FY2023 (+271.0%), $4.92 million in FY2022 and $318,000 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Interest & Investment Income since Q4 2024.
  • Year-over-year, Interest & Investment Income increased in four of the last eight quarters, with growth averaging 15.2%.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2022 (growth of 567.6%), and the weakest in Q3 2025 (a decline of 26.5%).
  • Business Quant data shows VRDN's Interest & Investment Income at $7.87 million (Q1 2026), $7.79 million (Q4 2025) and $5.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Viridian Therapeutics, Inc.\DE 2.20 Bn 2.20 Bn - 8.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.49 Mn
Mar 31, 2026 7.87 Mn
Dec 31, 2025 7.79 Mn
Sep 30, 2025 5.52 Mn
Jun 30, 2025 6.55 Mn
Mar 31, 2025 7.54 Mn
Dec 31, 2024 8.52 Mn
Sep 30, 2024 7.52 Mn
Jun 30, 2024 7.79 Mn
Mar 31, 2024 7.94 Mn
Dec 31, 2023 5.21 Mn
Sep 30, 2023 4.16 Mn
Jun 30, 2023 4.38 Mn
Mar 31, 2023 4.49 Mn
Dec 31, 2022 3.45 Mn
Sep 30, 2022 1.04 Mn
Jun 30, 2022 227,000.00
Mar 31, 2022 196,000.00
Dec 31, 2021 138,000.00
Sep 30, 2021 91,000.00
API Access

Viridian Therapeutics, Inc.\DE Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=VRDN&period=max&api_key=YOUR_API_KEY